カンジダ感染検査の世界市場レポート 2025年

カンジダ感染検査市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.2％で、212億9,000万米ドルに成長します。予測期間の成長は、新しいカンジダ株の出現、真菌感染症に対する意識の高まり、ヘルスケアアクセスの拡大、高齢化、意識の高まり、予防医療に起因すると考えられます。予測期間の主な動向には、分子診断の進歩、デジタルヘルス技術の統合、AIの統合、機械学習の統合、個別化医療などがあります。

酵母感染症の有病率の増加は、カンジダ感染検査市場の拡大を促進すると予測されます。カンジダ菌の過剰増殖によって引き起こされる酵母感染症は、一般的に口、性器、皮膚などの部位に影響を及ぼし、かゆみ、発赤、不快感などの症状を引き起こします。体内の自然細菌のバランスの乱れ、免疫システムの弱体化、ホルモンの変化などが、カンジダの過剰増殖の主な要因です。カンジダ感染検査は、これらの感染症の診断において重要な役割を果たし、ヘルスケアプロバイダーがカンジダの存在を確認し、適切な治療を決定することを可能にします。例えば、2023年9月のGOV.UKによると、イングランドにおけるイースト菌による血流感染症の割合は、2022年には人口10万人当たり4人に増加し、2021年から4％上昇しました。このようなイースト菌感染症の増加動向は、カンジダ感染検査市場の成長を促進すると予想されます。

カンジダ感染検査市場の主要企業は、カンジダ菌検出のための全自動PCR迅速検査など、先進技術ソリューションの開発にますます注力しています。これらのハイテク診断ツールは、ポリメラーゼ連鎖反応（PCR）技術を利用し、臨床サンプル中のカンジダ種を迅速かつ正確に検出します。例えば、2024年5月、ドイツに本社を置く医療技術企業Bosch Healthcare Solutions GmbHは、Vivalyticプラットフォーム上でカンジダ・オーリス検出用のPCR検査を発表しました。この検査は、ポイント・オブ・ケアで1時間以内に完全自動化された迅速な結果を提供するもので、集中型検査室で通常1～3日かかる従来の培養法と比べて所要時間を大幅に短縮します。この技術革新は、臨床現場やリスクの高い患者にとって特に価値があり、重篤なC. auris感染症のタイムリーな診断と治療を可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界カンジダ感染検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のカンジダ感染検査市場：成長率分析
• 世界のカンジダ感染検査市場の実績：規模と成長, 2019-2024
• 世界のカンジダ感染検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界カンジダ感染検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のカンジダ感染検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 侵襲性カンジダ症
• カンジデミア
• 世界のカンジダ感染検査市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 膣pH検査
• 核酸増幅検査（NAAT）
• マイクロバイオーム検査
• 世界のカンジダ感染検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 研究室
• 世界のカンジダ感染検査市場侵襲性カンジダ症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組織生検検査
• 尿培養検査
• 血液培養検査
• 世界のカンジダ感染検査市場カンジダ症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 血清学的検査
• 分子検査

第7章 地域別・国別分析

• 世界のカンジダ感染検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のカンジダ感染検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• カンジダ感染検査市場：競合情勢
• カンジダ感染検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Hologic Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• QIAGEN N.V.
• Cepheid
• Randox Laboratories Ltd.
• Meridian Bioscience Inc.
• DiaSorin S.p.A.
• Sekisui Diagnostics LLC
• Enzo Biochem Inc.
• T2 Biosystems Inc.
• Aidian Oy
• SafeCare LLC
• CHROMagar

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• カンジダ感染検査市場2029：新たな機会を提供する国
• カンジダ感染検査市場2029：新たな機会を提供するセグメント
• カンジダ感染検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Candida infection testing involves diagnostic procedures used to detect the presence of Candida species, which are fungi that can lead to infections in different parts of the body. These tests help identify the type and severity of the Candida infection, allowing for appropriate treatment planning.

The primary types of Candida infection testing are for invasive candidiasis and candidemia. Invasive candidiasis is a serious fungal infection that occurs when Candida yeast enters the bloodstream, spreading to various organs such as the heart, brain, eyes, bones, and other tissues. Testing methods include vaginal pH tests, nucleic acid amplification testing (NAAT), and microbiome tests, applied in settings such as hospitals and laboratories.

The candida infection testing market research report is one of a series of new reports from The Business Research Company that provides candida infection testing market statistics, including candida infection testing industry global market size, regional shares, competitors with a candida infection testing market share, detailed candida infection testing market segments, market trends and opportunities, and any further data you may need to thrive in the candida infection testing industry. This candida infection testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The candida infection testing market size has grown strongly in recent years. It will grow from $15.69 $ billion in 2024 to $16.72 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the rising incidence of candida infections, growing awareness and diagnostics, expansion of healthcare infrastructure, rise in hospital-acquired infections, and increasing funding for research.

The candida infection testing market size is expected to see strong growth in the next few years. It will grow to $21.29 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the emergence of new candida strains, rising awareness of fungal infections, expansion of healthcare access, aging population, rising awareness and preventive healthcare. Major trends in the forecast period include advancements in molecular diagnostics, integration of digital health technologies, integration of AI, integration of machine learning, and personalized medicine.

The growing prevalence of yeast infections is anticipated to drive the expansion of the candida infection testing market. Yeast infections, caused by the overgrowth of the fungus Candida, commonly affect areas such as the mouth, genitals, and skin, leading to symptoms such as itching, redness, and discomfort. Factors such as imbalances in the body's natural bacteria, weakened immune systems, and hormonal changes are key contributors to Candida overgrowth. Candida infection testing plays a crucial role in diagnosing these infections, enabling healthcare providers to confirm the presence of Candida and determine the appropriate treatment. For example, according to GOV.UK in September 2023, the rate of bloodstream infections caused by yeast in England increased to 4.0 per 100,000 population in 2022, reflecting a 4% rise from 2021. This upward trend in yeast infections is expected to fuel growth in the candida infection testing market.

Major players in the candida infection testing market are increasingly focusing on developing advanced technological solutions, such as fully automated PCR rapid tests for detecting Candida. These high-tech diagnostic tools utilize polymerase chain reaction (PCR) technology to provide quick and accurate detection of Candida species in clinical samples. For instance, in May 2024, Bosch Healthcare Solutions GmbH, a medical technology company based in Germany, introduced a PCR test for Candida auris detection on the Vivalytic platform. This test offers fully automated, rapid results within one hour at the point of care, significantly reducing the time required compared to traditional culture methods, which typically take one to three days in centralized laboratories. This innovation is particularly valuable for clinical settings and high-risk patients, enabling timely diagnosis and treatment of serious C. auris infections.

In February 2024, Bruker Corporation, a US-based provider of scientific instruments and analytical solutions, announced the completion of its acquisition of ELITechGroup for approximately €870 million (around $942 million) in cash. This acquisition is a strategic step for Bruker to expand its portfolio in molecular diagnostics and infectious disease testing by incorporating ELITech's innovative technologies and expertise. ELITechGroup, based in France, is a global leader in the in vitro diagnostics (IVD) industry.

Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC

North America was the largest region in the candida infection testing market in 2023. The regions covered in the candida infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the candida infection testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The candida infection testing market includes revenues earned by entities by providing services such as diagnostic testing services, culture testing, consultation services, training and support, and microscopic examination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Candida Infection Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on candida infection testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for candida infection testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The candida infection testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Invasive Candidiasis; Candidemia
• 2) By Test Type: Vaginal pH Test; Nucleic Acid Amplification Testing (NAAT); Microbiome Test
• 3) By Application: Hospital; Laboratory
• Subsegments:
• 1) By Invasive Candidiasis: Tissue Biopsy Testing; Urine Culture Testing; Blood Culture Testing
• 2) By Candidemia: Blood Tests; Serological Testing; Molecular Testing
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Candida Infection Testing Market Characteristics

3. Candida Infection Testing Market Trends And Strategies

4. Candida Infection Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Candida Infection Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Candida Infection Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Candida Infection Testing Market Growth Rate Analysis
• 5.4. Global Candida Infection Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Candida Infection Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Candida Infection Testing Total Addressable Market (TAM)

6. Candida Infection Testing Market Segmentation

• 6.1. Global Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Invasive Candidiasis
• Candidemia
• 6.2. Global Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaginal pH Test
• Nucleic Acid Amplification Testing (NAAT)
• Microbiome Test
• 6.3. Global Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Laboratory
• 6.4. Global Candida Infection Testing Market, Sub-Segmentation Of Invasive Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Biopsy Testing
• Urine Culture Testing
• Blood Culture Testing
• 6.5. Global Candida Infection Testing Market, Sub-Segmentation Of Candidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Serological Testing
• Molecular Testing

7. Candida Infection Testing Market Regional And Country Analysis

• 7.1. Global Candida Infection Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Candida Infection Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Candida Infection Testing Market

• 8.1. Asia-Pacific Candida Infection Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Candida Infection Testing Market

• 9.1. China Candida Infection Testing Market Overview
• 9.2. China Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Candida Infection Testing Market

• 10.1. India Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Candida Infection Testing Market

• 11.1. Japan Candida Infection Testing Market Overview
• 11.2. Japan Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Candida Infection Testing Market

• 12.1. Australia Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Candida Infection Testing Market

• 13.1. Indonesia Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Candida Infection Testing Market

• 14.1. South Korea Candida Infection Testing Market Overview
• 14.2. South Korea Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Candida Infection Testing Market

• 15.1. Western Europe Candida Infection Testing Market Overview
• 15.2. Western Europe Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Candida Infection Testing Market

• 16.1. UK Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Candida Infection Testing Market

• 17.1. Germany Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Candida Infection Testing Market

• 18.1. France Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Candida Infection Testing Market

• 19.1. Italy Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Candida Infection Testing Market

• 20.1. Spain Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Candida Infection Testing Market

• 21.1. Eastern Europe Candida Infection Testing Market Overview
• 21.2. Eastern Europe Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Candida Infection Testing Market

• 22.1. Russia Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Candida Infection Testing Market

• 23.1. North America Candida Infection Testing Market Overview
• 23.2. North America Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Candida Infection Testing Market

• 24.1. USA Candida Infection Testing Market Overview
• 24.2. USA Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Candida Infection Testing Market

• 25.1. Canada Candida Infection Testing Market Overview
• 25.2. Canada Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Candida Infection Testing Market

• 26.1. South America Candida Infection Testing Market Overview
• 26.2. South America Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Candida Infection Testing Market

• 27.1. Brazil Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Candida Infection Testing Market

• 28.1. Middle East Candida Infection Testing Market Overview
• 28.2. Middle East Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Candida Infection Testing Market

• 29.1. Africa Candida Infection Testing Market Overview
• 29.2. Africa Candida Infection Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Candida Infection Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Candida Infection Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Candida Infection Testing Market Competitive Landscape And Company Profiles

• 30.1. Candida Infection Testing Market Competitive Landscape
• 30.2. Candida Infection Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Candida Infection Testing Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. bioMerieux SA
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Bruker Corporation
• 31.5. QIAGEN N.V.
• 31.6. Cepheid
• 31.7. Randox Laboratories Ltd.
• 31.8. Meridian Bioscience Inc.
• 31.9. DiaSorin S.p.A.
• 31.10. Sekisui Diagnostics LLC
• 31.11. Enzo Biochem Inc.
• 31.12. T2 Biosystems Inc.
• 31.13. Aidian Oy
• 31.14. SafeCare LLC
• 31.15. CHROMagar

32. Global Candida Infection Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Candida Infection Testing Market

34. Recent Developments In The Candida Infection Testing Market

35. Candida Infection Testing Market High Potential Countries, Segments and Strategies

• 35.1 Candida Infection Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Candida Infection Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Candida Infection Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer